Eurepa-V

Eurepa-V 0.5/0.3 Tablet is prescribed for people with type 2 diabetes to help control high blood sugar levels. It works best along with diet and exercise to keep blood sugar within a healthy range.

No. Eurepa-V 0.5/0.3 Tablet does not cure diabetes. It helps manage type 2 diabetes by keeping blood sugar levels under control, which reduces the risk of complications like kidney problems, eye issues, and heart disease.

Eurepa-V 0.5/0.3 Tablet should not be taken by people if they have type 1 diabetes, severe liver disease, diabetic ketoacidosis, a blocked intestine, or are allergic to any of its ingredients. It is also not recommended for people under 18 years or over 75 years of age.

Yes. Eurepa-V 0.5/0.3 Tablet can sometimes lower your blood sugar too much, especially if you skip meals, exercise more than usual, or take it with certain other medicines. Signs of low blood sugar include sweating, dizziness, fast heartbeat, shakiness, and confusion.

Serious side effects of Eurepa-V 0.5/0.3 Tablet may include severe allergic reactions (swelling, difficulty breathing, fast heartbeat), chest pain, liver problems, or loss of consciousness due to very low blood sugar. If you experience any of these symptoms, seek immediate medical attention.

There have been reports suggesting a possible increased risk of acute coronary events with repaglinide (present in Eurepa-V 0.5/0.3 Tablet) in some studies. If you develop chest pain or other heart symptoms, seek urgent medical attention and tell your doctor you take this medicine.

Yes. Voglibose, present in Eurepa-V 0.5/0.3 Tablet, is not suitable for people with gastrointestinal obstruction or a predisposition to it, and it can cause increased intestinal gas that may worsen certain gut conditions. Tell your doctor if you have had bowel surgery, chronic intestinal disease, or symptoms of obstruction.